🌏Across the globe, our partners play a vital role in helping us bring breakthrough technologies and innovation to life and deliver our products to more people. 💡Discover how our partners are helping us accelerate innovation, scale our reach, and transform the future of diagnostics. Learn more: https://lnkd.in/gXBf8f2v
About us
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
- Website
-
http://www.cepheid.com
External link for Cepheid
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Sunnyvale, CA
- Type
- Public Company
- Founded
- 1996
- Specialties
- Molecular Diagnostics, Genetic Testing, Molecular Biology, Infectious Diseases, Cancer, and PCR
Locations
-
Primary
Get directions
904 Caribbean Drive
Sunnyvale, CA 94089, US
-
Get directions
Vira Solelh
Maurens-Scopont, 81470, FR
-
Get directions
Aston Court
Kingsmead Business Park, Frederick Place
High Wycombe, Buckinghamshire HP11 1LA, GB
-
Get directions
Röntgenv 2
Solna, 171 54, SE
Employees at Cepheid
Updates
-
Cepheid reposted this
Chief Medical Officer, Cepheid | Professor Adjoint- Infectious Diseases, University of Colorado
Atlanta, I’m heading your way for IDWeek™ 2025 (Oct 19-22) 🍑 I’m honored to attend in my new role as Cepheid's Chief Medical Officer. Let’s connect and collaborate to bring smarter solutions from bench to bedside. I’m especially focused on diagnostic stewardship of syndromic panels. ⬇️ Check out the sessions I’m attending—join me and share what’s on your agenda. 📅 Register for the symposium here: https://lnkd.in/eHKP3Put 💡 Learn more about IDWeek here: https://idweek.org/ Looking forward to a great week! #IDWeek2025 #infectiousdisease #diagnosticstewardship #syndromicpanels #moleculardiagnostics
-
-
Over 1 billion people globally live with a mental health condition.* Of these, anxiety and depression are the most common, yet care remains out of reach for many. It’s important to stand with those advocating for access, awareness, and compassion today and everyday. #WorldMentalHealthDay #MentalHealthMatters *https://lnkd.in/g9VyKuUP
-
-
Read the latest on Cepheid's Insight Hub: In Memory of John Bishop: A Visionary Leader in Molecular Diagnostics https://ow.ly/b75M50X8e18
-
Anne Muregi, Senior Director, Commercial Operations at Cepheid, leads commercial and market access programs, promoting equitable healthcare access and enhancing the company's mission in Africa. Join your passion and profession by learning more about Careers at Cepheid. https://lnkd.in/gGn8t6dn #LifeAtCepheid #Diagnostics #InnovationInHealthcare #CareersThatMatter
-
-
An estimated 2.3 million women were diagnosed with breast cancer in 2022. By 2050, that number is projected to rise nearly 40% to 3.2 million cases. Timely detection, fast diagnosis, and access to high-quality care are essential to improving outcomes and saving lives.* #MolecularDiagnostics #BreastCancerAwarenessMonth *https://lnkd.in/gyZp_Ufm CE-IVD. In Vitro Diagnostic Medical Device. Not all tests available in all countries.
-
Cepheid is a proud bronze sponsor at the 41st NRL Workshop on Infectious Diseases Testing #NRLWS2025 We look forward to meeting you there and don’t miss our expert-lead symposium as Marcela Romano presents on Mater Pathology’s verification of the Xpert® HIV-1 Viral Load XC assay. Title: “Counting on Accuracy: HIV Viral Load Verification Unpacked” Date: Friday, 10th October 2025 Venue: Apollo Room, Mantra Legends Time: 10.00–10.125 RSVP and Save the Date Now: https://ow.ly/4AeZ50X8e8P
-
-
🚨 Scott Sugden, Ph.D., Sr. Director of Medical Affairs at Cepheid Canada, breaks down why PCR-based molecular testing continues to lead the way in diagnostic accuracy—especially when compared to antigen testing. 📌 Read the latest on Cepheid's Insight Hub for key takeaways: https://ow.ly/lqrI50X2nnO
-
At IDWeek, learn how #PCR testing from Cepheid can help support antibiotic stewardship efforts with speed, accuracy, and flexibility. #AntimicrobialStewardship #InfectiousDiseases https://idweek.org/
-
-
At Cepheid, we ❤️ supporting our customers around the world. Meet part of the Cepheid Global Customer Care Team in the U.S.: #BetterTogether